Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Role of neuromelanin in neuronal damage

Oct. 22, 1998

Ondansetron effective and safe in controlling TD and psychotic symptoms

Oct. 22, 1998

New treatment for AD now marketed in Germany

Oct. 22, 1998

Delta-opioid agonists considered to have potential for improving PD symptoms

Oct. 22, 1998

SIB-1508Y exerts neuroprotective effects in addition to beneficial motor/cognitive actions

Oct. 22, 1998

Animal studies with KW-6002, a novel therapeutic for PD, presented at international congress

Oct. 22, 1998

Elevated levels of homocysteine a potential risk factor in AD

Oct. 22, 1998

Toyama licenses neuroprotective compound from Senju

Oct. 22, 1998

Lomerizine, a new antimigraine agent, compared to flunarizine in rats

Oct. 22, 1998

Dopaminergic and serotonergic agents synthesized at Lundbeck

Oct. 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...